Clinical trial
Single Subject Neratinib in Bladder Cancer
NCT01956253 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Subject Neratinib in Bladder Cancer
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- July 31, 2013
- Completion date
- June 30, 2014
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer